FDA backs EndoStim’s neurostimulation implant for GERD control

The FDA has granted breakthrough device designation to EndoStim for its implantable device which serves as a treatment option for patients with refractory gastroesophageal reflux disease, according to a manufacturer release.The EndoStim System is a neurostimulation device which is implanted laparoscopically and designed to provide long-term reflux control via automatically delivered mild electrical signals to the lower esophageal sphincter throughout the day. Programmed wirelessly by the physician, the system “automatically stimulates” the lower esophageal sphincter without anyRead More

Generated by Feedzy